Bradmer Pharmaceuticals Inc. (the "Corporation") (TSX VENTURE:BMR.H) announced
today that Perry N. Dellelce has resigned as a director of the Corporation. He
will continue to act as a consultant to the Corporation. The Corporation thanks
Mr. Dellelce for his commitment and significant past contribution to the
Corporation.


NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS
DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Bradmer Pharmaceuticals Inc.
Paul Van Damme
Chief Financial Officer
416.847.6905
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Bradmer Pharmaceuticals
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Bradmer Pharmaceuticals